A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...
A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
The findings could lead to genetic tests that predict the likelihood of disease recurrence in breast cancer patients and ...
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback